Company Overview and News

2
The Tell: Morgan Stanley upgrades emerging-market currencies as U.S. stocks outperform

3h marketwatch
Strategists at Morgan Stanley on Monday raised their rating on emerging-market currencies and bonds to neutral from negative, in part because they viewed global risks as more moderate than earlier projections.
MS MSCI

2
MSCI / MSCI, Inc. null

2018-09-22 sec.gov
begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C$P(# @;V)J#3P\+TQI;F5A#0IE;F1S M=')E86T-96YD;V)J#7-T87)T>')[email protected]*, T*)25%3T8-"B @(" @(" @#0HR M,B P(&]B:@T\/"]&:6QT97(O1FQA=&5$96-O9&4O22 X-"],(#8X+TQE;F=T M:" V,2]3(#,X/CYS=')E86T-"FC>[email protected][email protected]
MSCI

2
FBM KLCI rises as Bursa share trade tops RM3.6b

2018-09-21 theedgemarkets
KUALA LUMPUR (Sept 21): The FBM KLCI closed 6.94 points or 0.38% higher, while value across Bursa Malaysia climbed to RM3.61 billion as investors reckoned that the China-US trade war appeared to be less harsh than expected.
1155 1023 MLYBY MLYNF BSMAF MSCI 7277 1818 CIMDF

2
Asian stocks extend recovery, China rallies on stimulus hopes

2018-09-21 theedgemarkets
TOKYO (Sep 21): Asian stocks extended gains on Friday thanks to Wall Street scoring all-time highs, as investors gravitated to the view that the latest exchange of tariffs between the United States and China may be less damaging than initially feared.
MSCI

2
Asian stocks extend recovery, China rallies on stimulus hopes

2018-09-21 reuters
TOKYO (Reuters) - Asian stocks extended gains on Friday thanks to Wall Street scoring all-time highs, as investors gravitated to the view that the latest exchange of tariffs between the United States and China may be less damaging than initially feared.
MSCI

2
Stocks climb as trade concerns ease, dollar slips

2018-09-20 theedgemarkets
NEW YORK (Sept 21): World stock markets rallied on Thursday, while the U.S. dollar slipped, amid expectations that fresh U.S. and Chinese tariffs on reciprocal imports will be less harsh than feared.
BLK MSCI

2
Wall Street hits new records as trade worries ease

2018-09-20 theage.com.au
World stock markets rallied on Thursday, with the Dow and S&P 500 setting new highs, while the US dollar slipped as investors viewed this week's fresh US and Chinese tariffs on imports as less harsh than initially feared.
BLK MSCI

2
Wall Street hits new records as trade worries ease

2018-09-20 smh.com.au
World stock markets rallied on Thursday, with the Dow and S&P 500 setting new highs, while the US dollar slipped as investors viewed this week's fresh US and Chinese tariffs on imports as less harsh than initially feared.
BLK MSCI

2
Stocks hit new highs as trade worries ease, dollar slips

2018-09-20 reuters
NEW YORK (Reuters) - World stock markets rallied on Thursday, with the Dow and S&P 500 setting new highs, while the U.S. dollar slipped as investors viewed this week’s fresh U.S. and Chinese tariffs on imports as less harsh than initially feared.
BLK MSCI

2
World stocks climb as trade concerns ease, dollar slips

2018-09-20 reuters
NEW YORK (Reuters) - World stock markets rallied on Thursday, while the U.S. dollar slipped, amid expectations that fresh U.S. and Chinese tariffs on reciprocal imports will be less harsh than feared.
BLK MSCI

2
Shares knocked lower after new U.S. tariff threat on Chinese goods

2018-09-17 reuters
LONDON (Reuters) - Stock markets headed south on Monday as investors took fright at news that Washington was set to announce a new round of tariffs on Chinese goods in the latest escalation of their trade conflict.
MSCI

2
Shares knocked lower after new US tariff threat on Chinese goods

2018-09-17 channelnewsasia
Stock markets headed south on Monday as investors took fright at news that Washington was set to announce a new round of tariffs on Chinese goods in the latest escalation of their trade conflict.
MSCI

2
Potential Benefits And Risks Of Preferred Stocks

2018-09-14 ishares
In the current market environment, preferred stocks have felt pressure from rising interest rates but have performed relatively well versus other high-yielding instruments.
JPXGY OSCUF LSE DTK TRI 8697 MSCI

2
Getting More Defensive In European Portfolios

2018-09-14 seekingalpha
This is the first of a two-part series on Turkey's financial crisis and Europe. In this post, we assess European equity risk and potential portfolio solutions. The second part will explore country-level risks to assess WisdomTree ETFs that may help mitigate Turkish contagion.
BNPZY WETF DB BNPQY BNPQF DXGE CS MSCI

2
RPT-COLUMN-Developed stocks can't ignore emerging laws of gravity much longer: McGeever

2018-09-14 reuters
LONDON, Sept 13 (Reuters) - The relationship between developed and emerging market equities has broken down, and by some measures, the fracture hasn’t been this deep in over 20 years.
DB MSCI

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to MSCI / MSCI, Inc. on message board site Silicon Investor.

EWJ : ISHARES MSCI JAPAN INDEX FD (AMEX) EWJ : ISHARES MSCI JAPAN INDEX FD (AMEX) EWJ : ISHARES MSCI JAPAN INDEX FD (AMEX)
CUSIP: 55354G100